Literature DB >> 9354966

Antibody responses against Em18 and Em16 serodiagnostic markers in alveolar and cystic echinococcosis patients from northwest China.

A Ito1, H Wen, P S Craig, L Ma, M Nakao, T Horii, X L Pang, M Okamoto, M Itoh, Y Osawa, X G Wang, Y H Liu.   

Abstract

Western blot analysis was carried out in order to evaluate new serodiagnostic markers, Em18 and Em16, for differentiation of alveolar echinococcosis (AE) from cystic echinococcosis (CE) using 36 serum samples from hydatid patients from Xinjiang, China, where AE and CE are both endemic and one double infection case has been reported. All AE cases except one (5/6) who exhibited a calcified lesion and a single case of double infection showed antibody responses against Em18 and Em16. Some of CE patient sera (6/22) showed antibody response against Em16 except one who showed that against Em18. Analyses of IgG subclass responses against Em18 and Em16 were carried out using all serum samples showing antibody responses against Em18 and/or Em16 (seven CE, five AE, and one AE + CE) and additional samples of three CE and 22 AE from Sichuan, China. IgG4 was the most predominant antibody subclass. Em18 and Em16 were recognized by both IgG4 and IgG1 (in most cases) or by either IgG4 or IgG1 (in minor cases) or by IgG3 (in very rare cases). Neither Em18 nor Em16 was recognized by IgG2 antibodies. The usefulness of Em18 and Em16 as potential new markers for serological differentiation of human AE and CE, respectively, is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354966     DOI: 10.7883/yoken1952.50.19

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  2 in total

1.  Echinococcosis infection diagnosed based on the histological findings of a lymph node involvement obtained by EUS-FNA.

Authors:  Kentaro Moriichi; Mikihiro Fujiya; Takuma Goto; Toshikatsu Okumura
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

Review 2.  Concepts in immunology and diagnosis of hydatid disease.

Authors:  Wenbao Zhang; Jun Li; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.